Royalty Pharma plcRoyalty Pharma plcRoyalty Pharma plc

Royalty Pharma plc

İşlem yok

Şirket borçlanma araçları

En kötü getiriye göre sıralanmış Royalty Pharma plc tahvillerinin listesi aşağıdadır. Yatırımcılar, piyasa dalgalanması dönemlerinde artan istikrarları nedeniyle genellikle bir şirketin tahvillerini tercih ederler. Fiyatları, getirileri ve diğer istatistikleri inceleyin ve güvenilir bir yatırım bulun.
Sembol
Getiri %
Fiyat %
Kupon %
Vade Tarihi
Ödenmemiş tutar
Nominal değer
S&P derecelendirmesi
Fitch reytingi
İhraççı
RPHC5824522Royalty Pharma Plc 5.9% 02-SEP-2054
6,05%98,14%5,900%2054-09-02500 M USD1.000,00 USD
BBB−
BBB
Royalty Pharma Plc
RPHC6166013Royalty Pharma Plc 5.95% 25-SEP-2055
5,98%99,18%5,950%2055-09-25500 M USD1.000,00 USD
BBB−
BBB
Royalty Pharma Plc
RPHC5222528Royalty Pharma Plc 3.35% 02-SEP-2051
5,97%65,93%3,350%2051-09-02700 M USD1.000,00 USD
BBB−
BBB
Royalty Pharma Plc
RPHC5237919Royalty Pharma Plc 3.55% 02-SEP-2050
5,92%69,09%3,550%2050-09-021 B USD1.000,00 USD
BBB−
BBB
Royalty Pharma Plc
RPHC5237891Royalty Pharma Plc 3.3% 02-SEP-2040
5,61%77,08%3,300%2040-09-021 B USD1.000,00 USD
BBB−
BBB
Royalty Pharma Plc
RPHC6166014Royalty Pharma Plc 5.2% 25-SEP-2035
5,19%99,84%5,200%2035-09-25900 M USD1.000,00 USD
BBB−
BBB
Royalty Pharma Plc
RPHC5824521Royalty Pharma Plc 5.4% 02-SEP-2034
5,11%101,93%5,400%2034-09-02500 M USD1.000,00 USD
BBB−
BBB
Royalty Pharma Plc
RPHC5222527Royalty Pharma Plc 2.15% 02-SEP-2031
4,69%88,01%2,150%2031-09-02600 M USD1.000,00 USD
BBB−
BBB
Royalty Pharma Plc
RPHC6166012Royalty Pharma Plc 4.45% 25-MAR-2031
4,58%99,43%4,450%2031-03-25600 M USD1.000,00 USD
BBB−
BBB
Royalty Pharma Plc
RPHC5237916Royalty Pharma Plc 2.2% 02-SEP-2030
4,55%90,58%2,200%2030-09-02999,8 M USD1.000,00 USD
BBB−
BBB
Royalty Pharma Plc
RPHC5824520Royalty Pharma Plc 5.15% 02-SEP-2029
4,43%102,08%5,150%2029-09-02500 M USD1.000,00 USD
BBB−
BBB
Royalty Pharma Plc
RPHC5237354Royalty Pharma Plc 1.75% 02-SEP-2027
4,29%96,63%1,750%2027-09-021 B USD1.000,00 USD
BBB−
BBB
Royalty Pharma Plc
RPHC5035520Royalty Pharma Plc 2.2% 02-SEP-2030
2,35%98,72%2,200%2030-09-023,19 M USD1.000,00 USD
BBB−
Royalty Pharma Plc